BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 339543)

  • 1. [S35 lipoic acid distribution and its effect on pyruvate dehydrogenase activity in rats with Walker carcinoma].
    Karpov LM; Dvuzhil'naia ED; Savvov VI; Phan Van Thuy
    Vopr Onkol; 1977; 23(10):87-90. PubMed ID: 339543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incorporation of S35-lipoate label in animal tissues at different times after tumor transplantation].
    Trebukhina RV; Mikhal'tsevich GN; Ostrovskiĭ IuM; Iakubchik TN
    Vopr Onkol; 1975; 21(7):96-100. PubMed ID: 766401
    [No Abstract]   [Full Text] [Related]  

  • 3. [Permeability of the mitochondrial membranes of the organs of white rats innoculated with Walker carcinoma to lipoic acid and thiamine labelled with S35].
    Karpov LM; Dvuzhil'naia ED; Savvov VI; Anisimov VD
    Vopr Onkol; 1975; 21(8):69-73. PubMed ID: 1101537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of Walker carcinoma on the distribution of S35-lipoic acid in the body of white rats].
    Karpov LM; Rozanov AIa; Savvov VI
    Vopr Onkol; 1973; 19(12):57-61. PubMed ID: 4595158
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lactate and pyruvate metabolism in the tissues of rats with Walker carcinosarcoma injected with oxythiamine].
    Velichko MG; Ostrovskiĭ IuM
    Eksp Onkol; 1984; 6(2):54-7. PubMed ID: 6510336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thiamine and pyruvate metabolism in tumor-bearing rats].
    Velichko MG; Ostrovskiĭ IuM; Trebukhina RV
    Vopr Med Khim; 1978; 24(2):220-4. PubMed ID: 664448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase.
    Korotchkina LG; Sidhu S; Patel MS
    Free Radic Res; 2004 Oct; 38(10):1083-92. PubMed ID: 15512796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Features of pyruvate and lactate metabolism in tumor-bearing rats following citrate administration].
    Velichko MG; Trebukhina RV; Ostrovskiĭ IuM
    Vopr Med Khim; 1981; 27(1):68-72. PubMed ID: 7467208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activity of the pyruvate dehydrogenase complex in Walker-256 carcinosarcoma].
    Nemeria NS; Trevukhina RV
    Ukr Biokhim Zh (1978); 1993; 65(4):28-33. PubMed ID: 8284814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered distribution and excretion of N-1-methylnicotinamide in rats with Walker 256 carcinosarcoma.
    Clark BR; Murai JT; Pomeranz A; Mills PA; Halpern RM
    Cancer Res; 1975 Jul; 35(7):1727-33. PubMed ID: 236826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoic acid residues in a take-over mechanism for the pyruvate dehydrogenase multienzyme complex of Escherichia coli.
    Berman JN; Chen GX; Hale G; Perham RN
    Biochem J; 1981 Dec; 199(3):513-20. PubMed ID: 6803766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pyruvate oxidation and S35-lipoic acid fixation by breast tumor homogenates].
    Savvov VI; Karpov LM
    Vopr Onkol; 1978; 24(8):97-9. PubMed ID: 211729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of alpha-lipoic acid enantiomers and homologues with the enzyme components of the mammalian pyruvate dehydrogenase complex.
    Löffelhardt S; Bonaventura C; Locher M; Borbe HO; Bisswanger H
    Biochem Pharmacol; 1995 Aug; 50(5):637-46. PubMed ID: 7669066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary lipoic acid-dependent changes in the activity and mRNA levels of hepatic lipogenic enzymes in rats.
    Huong DT; Ide T
    Br J Nutr; 2008 Jul; 100(1):79-87. PubMed ID: 18062843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mimic of the pyruvate dehydrogenase complex.
    Zhao H; Breslow R
    Bioorg Med Chem Lett; 2010 Oct; 20(20):5973-5. PubMed ID: 20826089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of lipoic acid in product formation by Enterococcus faecalis NCTC 775 and reconstitution in vivo and in vitro of the pyruvate dehydrogenase complex.
    Snoep JL; van Bommel M; Lubbers F; Teixeira de Mattos MJ; Neijssel OM
    J Gen Microbiol; 1993 Jun; 139 Pt 6():1325-9. PubMed ID: 8360624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of a new triazine antifolate in mice, rats, dogs, and monkeys.
    Cashmore AR; Skeel RT; Makulu DR; Gralla EJ; Bertino JR
    Cancer Res; 1975 Jan; 35(1):17-22. PubMed ID: 803254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tumor necrosis factor alpha on skeletal muscle and Walker 256 carcinosarcoma protein metabolism studied in vivo.
    Tayek JA; Brasel JA
    Cancer Res; 1990 May; 50(9):2765-8. PubMed ID: 2328503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.
    Dubel L; Tanaka A; Leung PS; Van de Water J; Coppel R; Roche T; Johanet C; Motokawa Y; Ansari A; Gershwin ME
    Hepatology; 1999 Apr; 29(4):1013-8. PubMed ID: 10094940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the capillary permeability of experimental liver metastases.
    Ackerman NB; Hechmer PA
    Surg Gynecol Obstet; 1978 Jun; 146(6):884-8. PubMed ID: 653561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.